Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
The research team, led by Avik Som, an MD/PhD student, and Samuel Achilefu, PhD, professor of radiology and of biochemistry & molecular biophysics in the School of Medicine and of biomedical engineering in the School of Engineering & Applied Science, in collaboration with two labs in the School of Engineering & Applied Science, used two novel methods to create nanoparticles from calcium carbonate that were injected intravenously into a mouse model to treat solid tumors. The compound changed the pH of the tumor environment, from acidic to more alkaline, and kept the cancer from growing.
With this work, researchers showed for the first time that they can modulate pH in solid tumors using intentionally designed nanoparticles. Results of the research were recently published online in Nanoscale.
“Cancer kills because of metastasis,” said Som, who is working on a doctorate in biomedical engineering in addition to a medical degree. “The pH of a tumor has been heavily correlated with metastasis. For a cancer cell to get out of the extracellular matrix, or the cells around it, one of the methods it uses is a decreased pH.”
The researchers set out to find new approaches to raise the pH of the tumor and do so only in the tumor environment. In water, the pH in calcium carbonate increases as high as 9. But when injected into the body, the team discovered that calcium carbonate only raises the pH to 7.4, the normal pH in the human body. However, working with calcium carbonate presented some challenges.
“Calcium carbonate doesn’t like to be small,” Som said. “Calcium carbonate crystals are normally 10 to 1,000 times bigger than an ideal nanoparticle for cancer therapy. On top of that, calcium carbonate in water will constantly try to grow, like stalactites and stalagmites in a cave.”
To solve this issue, Som worked with other researchers in the School of Engineering & Applied Science to create two unique solutions. Teaming up with researchers in the lab of Pratim Biswas, PhD, the Lucy & Stanley Lopata Professor and chair of the Department of Energy, Environmental & Chemical Engineering, they developed a method using polyethyleneglycol-based diffusion to synthesize 20- and 300-nanometer-sized calcium carbonate.
Working with Srikanth Singamaneni, PhD, assistant professor of materials science, they developed another method to create 100-nanometer-sized calcium carbonate by building on a method known as ethanol-assisted diffusion. By harnessing the complementary expertise of the different labs, the researchers developed a solvent made of albumin to keep the calcium carbonate nanoparticles from growing, allowing them to be injected into the body intravenously.
Commonly, nanoparticles have been made with gold and silver. However, neither are present in the human body, and there are concerns about them accumulating in the body.
“Calcium and carbonate are both found heavily in the body, and they are generally non-toxic,” Som said. “When calcium carbonate dissolves, the carbonate becomes carbon dioxide and is released through the lungs, and calcium is often incorporated into the bones.”
Som and the team injected the calcium carbonate nanoparticles into the mouse fibrosarcoma model daily, which kept the tumor from growing. However, when they stopped injecting the nanoparticles, it started growing again.
Going forward, the researchers plan to determine the optimal dose to prevent metastasis, improve targeting to tumors and determine if it could be used with chemotherapy drugs.
The Latest on: Cancerous tumor
via Google News
The Latest on: Cancerous tumor
- How a coat covered in asbestos led to one woman's cancer diagnosis 30 years lateron June 26, 2020 at 10:13 am
Heather Von St. James was diagnosed with malignant pleural mesothelioma, a cancer of the lining of the lungs, not long after her daughter was born in 2005. She only gained five pounds during her ...
- Incidence of thyroid cancer has doubled globally, analysis findson June 26, 2020 at 9:00 am
The number of people diagnosed with thyroid cancer has more than doubled worldwide since 1990, fueled by a rise in cases in Asia. The United States accounts for 10 percent of cases worldwide.
- Covid-19 unmasks what cancer patients have long knownon June 26, 2020 at 4:30 am
The pandemic has laid bare shortcomings in the global health system that have harmed patients of cancer and other diseases for decades, writes Princess Dina Mired of Jordan, president of the Union for ...
- Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expressionon June 26, 2020 at 2:10 am
Polyamine metabolism is frequently dysregulated in cancers. Here, the authors show that a polyamine biosynthetic enzyme, spermine synthase, is overexpressed in colorectal cancers and cooperates with ...
- I’m A Physician Who Had Breast Cancer, And Here Are The Knowledge-Based Decisions I Made For Myselfon June 25, 2020 at 6:43 pm
I have cancer and it sucks. I don’t tell my kids everything because it wouldn’t help them. But I try to be open and honest.
- Cancer Immunotherapy Tied to Severe COVID-19 Outcomeson June 25, 2020 at 1:22 pm
Cancer patients receiving immunotherapy were at increased risk for severe outcomes from COVID-19, according to retrospective findings from Memorial Sloan Kettering Cancer Center in New York City.
- Unique Genetic Characteristics and Clinical Prognosis of Female Patients with Lung Cancer Harboring RET Fusion Geneon June 25, 2020 at 2:24 am
Since no report on the genetic characteristics of RET fusions in female patients with lung cancer is available, this study revealed the genetic and prognostic characteristics of female patients with ...
- Colorectal Cancer Highlights from ASCO 2020on June 24, 2020 at 4:23 pm
H or MMRd metastatic colorectal cancer, and other key CRC results presented during the ASCO 2020 virtual meeting are discussed by Dr Benjamin Weinberg.
- Highlights in Ovarian Cancer From ASCO 2020on June 24, 2020 at 1:31 pm
Dr Maurie Markman reports on key ovarian cancer presentations from ASCO 2020, including the eagerly awaited DESKTOP III trial, results of maintenance olaparib from the SOLO-2, and the PAOLA-1 study.
- Bayer reaches over $10 billion settlement in Roundup cancer lawsuitson June 24, 2020 at 1:30 pm
Monsanto, which Bayer bought in 2018, lost a lawsuit that same year brought by a school groundskeeper claiming its weedkiller caused his non-Hodgkin lymphoma.
via Bing News